• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Previous Issues
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Parasitologists United Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2025)
Volume Volume 17 (2024)
Volume Volume 16 (2023)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 15 (2022)
Volume Volume 14 (2021)
Volume Volume 13 (2020)
Volume Volume 12 (2019)
Volume Volume 11 (2018)
Volume Volume 10 (2017)
Abo-Hussien, N., Soliman, S., Sweed, D., Mandour, S., Abokhalil, N., Atia, A. (2023). Evaluation of the therapeutic efficacy of curcumin nanoparticles in the intestinal and muscular phases of murine trichinosis. Parasitologists United Journal, 16(3), 230-245. doi: 10.21608/PUJ.2023.242480.1228
Noha Abo-Hussien; Shaimaa Soliman; Dina Sweed; Sally Mandour; Noha Abokhalil; Amany Atia. "Evaluation of the therapeutic efficacy of curcumin nanoparticles in the intestinal and muscular phases of murine trichinosis". Parasitologists United Journal, 16, 3, 2023, 230-245. doi: 10.21608/PUJ.2023.242480.1228
Abo-Hussien, N., Soliman, S., Sweed, D., Mandour, S., Abokhalil, N., Atia, A. (2023). 'Evaluation of the therapeutic efficacy of curcumin nanoparticles in the intestinal and muscular phases of murine trichinosis', Parasitologists United Journal, 16(3), pp. 230-245. doi: 10.21608/PUJ.2023.242480.1228
Abo-Hussien, N., Soliman, S., Sweed, D., Mandour, S., Abokhalil, N., Atia, A. Evaluation of the therapeutic efficacy of curcumin nanoparticles in the intestinal and muscular phases of murine trichinosis. Parasitologists United Journal, 2023; 16(3): 230-245. doi: 10.21608/PUJ.2023.242480.1228

Evaluation of the therapeutic efficacy of curcumin nanoparticles in the intestinal and muscular phases of murine trichinosis

Article 9, Volume 16, Issue 3, December 2023, Page 230-245  XML PDF (1.07 MB)
Document Type: Original Article
DOI: 10.21608/PUJ.2023.242480.1228
View on SCiNiTO View on SCiNiTO
Authors
Noha Abo-Hussien1; Shaimaa Soliman2; Dina Sweed3; Sally Mandour4; Noha Abokhalil email 5; Amany Atia6
1Departments of Medical Parasitology , Faculty of Medicine , Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
2Departments of Public Health and Community Medicine , Faculty of Medicine, Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
3Departments of Pathology, National Liver Institute Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
4Departments of Clinical Pathology National Liver Institute ,Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
5Departments of Medical Parasitology, Faculty of Medicine,Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
6Departments of Medical Parasitology,Faculty of Medicine Menoufia University, Shebin El-Kom, Menoufia Governorate, Egypt
Abstract
Background: Curcumin (Cur) exhibits anti-parasitic effects in spite of its poor bioavailability. However,
several studies documented use of nanotechnology as efficient drug delivery system.
Objective: To investigate the effect of Cur nanoparticles (Cur-Nano) alone and in combination with
albendazole (ABZ) on murine trichinosis.
Material and Methods: A total of 150 laboratory-bred, male Swiss Albino mice were divided randomly
and equally into three groups; (I) the intestinal group; (II) the early-treated muscular group; and (III) the
late-treated muscular group. Each group was subdivided equally into five subgroups; (a) negative control
group; (b) infected non-treated (positive control); (c) mice infected and treated by ABZ; (d) mice infected
and treated by Cur-Nano and (e) mice infected and treated by both drugs. Mice were sacrificed on the
7th day post-infection (dpi) (GI) and on the 49th dpi (GII and GIII). The intestinal and muscle specimens
were used for H&E, Masson’s trichrome, and toluidine blue. Additional study parameters included levels
of creatine kinase (CK) to assess degree of muscle destruction, expression levels of vascular endothelial
growth factor (VEGF) as well as serum and muscle matrix metalloproteinase 9 (MMP9) to investigate Cur
anti-angiogenetic activity, and malonaldehyde (MDA), and total antioxidant capacity (TAC) to determine
its anti-oxidant effects.
Results: All treated subgroups showed a significant reduction in adult worm and larval count, with
the highest reduction of 99.325 % and 95.94% in GIe and GIIIe respectively. There was a significant
improvement in the inflammatory response with significantly decreased expression of VEGF. In both early
and late treated mice, serum CK, MDA and MMP9 levels were decreased with improved TAC levels in mice
treated with combined treatment and Cur-Nano.
Conclusion: Nanoparticles proved effective drug delivery system for Cur against trichinosis with
noticeable outcomes in the muscle phase. The synergistic activity of ABZ/Cur-Nano gives the best results
in both intestinal and muscular phases.
Keywords
Albendazole; angiogenesis; anti-inflammatory; antioxidant; curcumin nanoparticles; MMP9, trichinosis; VEGF
Statistics
Article View: 183
PDF Download: 543
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.